Work

Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program

Year: 2020

Type: article

Study design: Observational Study

Source: Drug Safety

DOI: 10.1007/s40264-020-01017-z

Authors: Ameet Sarpatwari, Mengdong He, Frazer A. Tessema, Joshua J. Gagne, Aaron S. Kesselheim

Institutions: Brigham and Women's Hospital, Harvard University

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Greenwall Foundation, Laura and John Arnold Foundation, Harvard-MIT Center for Regulatory Science

OpenAlex ID: W3103374882

FWCI: 0.631

Cites: 14

Cited by: 9

Related to: 10